https://www.facebook.com/298051530222483/

Cedith pharmaceuticals & Cedith Clinical Pharmacy, 43 CHURCHILL RD,BORIKIRI, Port Harcourt (2025)

07/09/2025

RESPIRATORY PHARMACY SPECIALISTS..

What do they do as specialists in healthcare ?

The high prevalence of both respiratory and non respiratory comorbidités ( diseases ), which lead to poorer results ( outcomes) in terms of quality of life and morbidity and deaths , makes it essential to understand the complexity of these ailments, not only in terms of medications but also in terms of the specific tests and techniques used in diagnosis and follow up.
According to Noe Garin et al, 2024, Pharmaceutical Care ( PC ) is key to the management of respiratory diseases due to complex treatments such as inhalers and nasal devices. These devices have been reported to be used correctly in one third of cases due to their complexity, variability, need for coordination, lung capacity, and use of chambers, among other factors.
Adherence is estimated to be 50% according to research, and records show that only 63% of prescriptions are filled. Other treatments should also be taken into account, such as biologics for asthma or polyposis, and oxygen therapy for chronic obstructive pulmonary disease ( COPD ) or interstitial lung disease ( ILD ).

A respiratory pharmacist is a specialist clinical pharmacist in respiratory care who provides medication treatment and management to patients with respiratory conditions such as asthma, cystic fibrosis, tuberculosis , interstitial lung disease, sleep medicine and COPD etc.
They review and amend medication plans and educate respiratory patients on the importance of following treatment regimens.
As the role of a respiratory pharmacist may differ day to day, the setting they work in, can frequently change too.
Members of the respiratory pharmacy team work in a variety of healthcare environments, such as hospitals, respiratory clinics, and community practices, to ensure safe and effective medication management for patients with respiratory conditions.
Alongside inhaled therapy, respiratory pharmacists can also focus on preventative measures for patients. This may include recommendations for seasonal immunizations, smoking cessation support, consideration of prophylactic antibiotics, rescue packs and medicines adherence education..

In the UK in 2003, the concept of Pharmacist Supplementary Prescriber was described by the UK Department of Health. It allowed an accredited Pharmacist to prescribe medicines to a patient within an agreed clinical management plan for a specific condition in collaboration with another prescriber such as physician or dentist.
In 2005, this was extended to offer PHARMACIST INDEPENDENT PRESCRIBING RIGHTS., which added the responsibility for the assessment, diagnosis and conséquent management of that patient.
To date , the independent prescribing course has only been completed by already qualified ( graduate ) pharmacists, but new standards mandate that all Pharmacists in the UK will be permitted to prescribe at the point of registration as a Pharmacist. That means that from year 2026, after successful completion of pharmacy degree and their foundation year training, all UK Pharmacists will have medicines prescribing authority.
A significant number of UK pharmacists, including those specializing in respiratory care, are already independent prescribers.
An independent prescriber can initiate, adapt, renew, or substitute prescriptions autonomously for patients within their clinical competency.
They can assess patient needs, check for drug interactions, ensure optimal drug administration, and provide support for non-pharmacological aspects of care, such as pulmonary rehabilitation.
While not all respiratory pharmacists are independent prescribers, those who have completed the necessary training are empowered to prescribe respiratory drugs independently, contributing significantly to patient care and medicines management in the UK.

Another important development for the pharmacy profession in the UK was the establishment of the CONSULTANT PHARMACIST CADRE introduced by the National Health Service (NHS ) in year 2005.
Consultant Pharmacists are recognized as leaders in the profession and clinical experts delivering care and driving change accross the healthcare system. Their purpose is primarily to undertake activities that use their extensive expert knowledge and skills to contribute to improving the health of individuals and the wider population.
The NHS in the UK promotes the integration of respiratory pharmacists into specialized services for conditions like severe asthma.
The British Thoracic Society ( BTS ) advocates for specialist respiratory pharmacists within the healthcare system and also has a pharmacist specialist advisory group.

In Australia, the respiratory pharmacy task force established by the Pharmaceutical Society of Australia ( PSA ), , as part of the respiratory care community of specialty interest, is made up of pharmacy Respiratory Experts, leaders within the pharmacy profession, consumers, respiratory physicians, GPs, and representatives from the lung foundation Australia. The task force will initially meet on asthma management and then extend to COPD etc.

According to Dr Anna Murphy, Consultant Respiratory Pharmacist ( NHS, UK) , community pharmacists in respiratory care have roles such as identifying "red flags " in people with respiratory complaints. These might be patients receiving frequent courses of antibiotics and steroids who have not yet got a diagnosis, or patients who are self treating persistent coughs. "It could be lung cancer or it could be COPD, or indeed could be asthma". Respiratory Pharmacists can actually help other pharmacists to identify and then to refer through to diagnosticians , and so on for diagnosis.

AFRICA, while specialist clinical pharmacy roles such as those in respiratory care are well established in Europe and North America, they are less common but emerging on the African Continent.
Clinical pharmacists in countries like South Africa are actively involved in managing respiratory conditions, focusing on areas such as COPD, and bronchiectasis.
The Doctor of Pharmacy program is a Postgraduate course in South Africa and the country is somewhat recognized as a leader of Clinical Pharmacy on the continent.
The Respiratory Pharmacist of Nigeria Specialty Group of the Clinical Pharmacists Association of Nigeria (CPAN) is also an example of a body of Pharmacists on the African Continent promoting the specialty area of Respiratory Pharmacy.

COURTESY.
African Society of Clinical Pharmacists (ASOCLIP).

Join ASOCLIP today to help advance Human Health and Clinical Pharmacy In African Countries & beyond.

To join ASOCLIP as a Pharmacist, kindly contact via WhatsApp:

+227 90 96 53 39,
+233 24 482 5108,
+2348033367881 ,
+256 779 816896 or
+234 803 723 3500.

( WhatsApp Chats only)

07/09/2025

SPÉCIALISTES DE LA PHARMACIE RESPIRATOIRE.

Que font-ils en tant que spécialistes de la santé?

La prévalence élevée des comorbidités respiratoires et non respiratoires (maladies), qui entraînent des résultats plus pauvres (résultats) en termes de qualité de vie, de morbidité et de mort, rend essentiel de comprendre la complexité de ces maux, non seulement en termes de médicaments, mais aussi en termes de tests et de techniques spécifiques utilisés dans le diagnostic et le suivi. Selon Noe Garin et al, 2024, les soins pharmaceutiques (PC) sont essentiels à la gestion des maladies respiratoires en raison de traitements complexes tels que les inhalateurs et les appareils nasaux. Ces dispositifs ont été signalés correctement dans un tiers des cas en raison de leur complexité, de leur variabilité, de leur besoin de coordination, de leur capacité pulmonaire et de leur utilisation des chambres, entre autres facteurs. L'adherence est estimée à 50% selon la recherche, et les enregistrements montrent que seulement 63% des ordonnances sont remplies. D'autres traitements doivent également être pris en compte, tels que la biologics pour l'asthme ou le polyposis, et la thérapie par l'oxygène pour la maladie pulmonaire obstructive chronique (MPOC) ou la maladie du poumon interstitielle (ILD).

Un pharmacien respiratoire est un pharmacien clinique spécialisé en soins respiratoires qui fournit un traitement et une gestion des médicaments aux patients souffrant d'affections respiratoires telles que l'asthme, la fibrose kystique, la tuberculose, les maladies pulmonaires interstitielles, la médecine du sommeil et la MPOC, etc. Ils examinent et modifient les plans de traitement et éduquent les patients respiratoires sur l'importance de suivre les régimes de traitement. Comme le rôle d'un pharmacien respiratoire peut différer de jour en jour, le réglage dans lequel ils travaillent peut souvent changer aussi. Les membres de l'équipe de la pharmacie respiratoire travaillent dans une variété d'environnements de santé, tels que les hôpitaux, les cliniques respiratoires et les pratiques communautaires, pour assurer une gestion sûre et efficace des médicaments pour les patients souffrant d'affections respiratoires. Aux côtés de la thérapie inhalée, les pharmaciens respiratoires peuvent également se concentrer sur des mesures préventives pour les patients. Cela peut inclure des recommandations pour les vaccinations saisonnières, le soutien à la cessation du tabagisme, la prise en compte des antibiotiques prophylactiques, des packs de sauvetage et des médicaments, l'éducation d'adhésion.

Au royaume-uni en 2003, le concept de prescription supplémentaire de pharmacien a été décrit par le département de la santé du royaume-uni. Il a permis à un pharmacien accrédité de prescrire des médicaments à un patient dans un plan de gestion clinique convenu pour un état spécifique en collaboration avec un autre prescripteur tel que le médecin ou le dentiste. En 2005, cela a été étendu pour offrir des DROITS DE PRESCRIPTION DE L'INDÉPENDANT PHARMACIEN., qui a ajouté la responsabilité de l'évaluation, du diagnostic et de la gestion conséquente de ce patient. À ce jour, le cours de prescription indépendant n'a été terminé que par des pharmaciens déjà qualifiés (diplômés), mais de nouveaux mandats de normes que tous les pharmaciens du royaume-uni seront autorisés à prescrire au point d'enregistrement en tant que pharmacien. Cela signifie qu'à partir de l'année 2026, après avoir obtenu un diplôme en pharmacie et leur formation en année de fondation, tous les pharmaciens du Royaume-Uni auront des médicaments prescrivant l'autorité. Un nombre important de pharmaciens britanniques, y compris ceux spécialisés dans les soins respiratoires, sont déjà des prescripteurs indépendants. Un prescripteur indépendant peut initier, adapter, renouveler ou remplacer les ordonnances de manière autonome pour les patients au sein de leur compétence clinique. Ils peuvent évaluer les besoins des patients, vérifier les interactions médicamenteuses, assurer une administration optimale des médicaments et fournir un soutien aux aspects non pharmacologiques des soins, tels que la réhabilitation pulmonaire. Bien que tous les pharmaciens respiratoires ne soient pas des prescripteurs indépendants, ceux qui ont suivi la formation nécessaire sont habilités à prescrire des médicaments respiratoires indépendamment, contribuant de façon importante à la gestion des soins aux patients et des médicaments au royaume-uni.

Un autre développement important pour la profession de pharmacie au Royaume-Uni a été la création du CADRE PHARMACIEN CONSULTANT présenté par le Service National de la Santé (NHS) en 2005. Les pharmaciens consultants sont reconnus comme des leaders de la profession et des experts cliniques offrant des soins et un changement de conduite à travers le système de santé. Leur but est principalement d'entreprendre des activités qui utilisent leurs connaissances et leurs compétences d'experts approfondis pour contribuer à améliorer la santé des individus et de la population en général. Le NHS au Royaume-Uni favorise l'intégration des pharmaciens respiratoires dans des services spécialisés pour des conditions telles que l'asthme sévère. La British Thoracic Society (BTS) préconise des pharmaciens respiratoires spécialisés dans le système de santé et dispose également d'un groupe consultatif spécialisé en pharmacien.

En australie, le groupe de travail de la pharmacie respiratoire établi par la société pharmaceutique d'australie (PSA), dans le cadre de la communauté de soins respiratoires de l'intérêt de spécialité, est constitué d'experts en soins respiratoires de la pharmacie dirigeants au sein de la profession de pharmacie, consommateurs, médecins respiratoires, GPs et représentants de la fondation pulmonaire Australie. Le groupe de travail se réunira d'abord sur la gestion de l'asthme, puis s'étendra à la MPOC, etc.

Selon le Dr Anna Murphy, le pharmacien respiratoire du conseiller (NHS, UK), les pharmaciens de la communauté dans les soins respiratoires ont des rôles tels que l'identification des «drapeaux rouges» chez les personnes ayant des plaintes respiratoires. Ce sont peut-être des patients qui reçoivent des cours fréquents d'antibiotiques et de stéroïdes qui n'ont pas encore eu de diagnostic, ou des patients qui se soignent de toux persistantes. « Il pourrait s'agir d'un cancer du poumon ou il pourrait s'agir de la MPOC, ou en effet pourrait être l'asthme ». Les pharmaciens respiratoires peuvent en fait aider d'autres pharmaciens à identifier, puis à se référer aux diagnosticiens, etc. pour le diagnostic.

L'AFRIQUE, tandis que des rôles spécialisés en pharmacie clinique tels que ceux des soins respiratoires sont bien établis en Europe et en Amérique du Nord, ils sont moins courants mais émergents sur le continent africain. Les pharmaciens cliniciens des pays comme l'Afrique du Sud sont activement impliqués dans la gestion des conditions respiratoires, en se concentrant sur des zones telles que la MPOC et la bronchiectase. Le programme docteur en pharmacie est un cours de troisième cycle en afrique du sud et le pays est un peu reconnu comme un leader de la pharmacie clinique sur le continent. Le pharmacien respiratoire du groupe de spécialité du nigéria de l'association des pharmaciens cliniques du nigéria (CPAN) est également un exemple d'un corps de pharmaciens sur le continent africain qui fait la promotion de la zone de spécialité de la pharmacie respiratoire.

COURTOISIE.

Société africaine de pharmaciens cliniques (ASOCLIP). *

Joignez-vous à ASOCLIP aujourd'hui pour aider à faire progresser la santé humaine et la pharmacie clinique dans les pays africains et au-delà.

Pour rejoindre ASOCLIP en tant que pharmacien, veuillez contacter via WhatsApp:

+227 90 96 53 39, +233 24482 5108, +2348033367881, +256 779 816896 ou +234 803 723 3500.

(Chats WhatsApp uniquement)

04/09/2025

Birthday Félicitations from Nigeria, West Africa.

CELEBRATING A COLOSSUS OF CLINICAL PHARMACY: A BIRTHDAY TRIBUTE TO DR. JOSEPH MADU

Our Dear Pioneer Chairman, Dr. Joseph Madu, BPharm, PharmD, FPCPharm, FPSN, SCPAN,_

On this auspicious day, the 4th of September, the entire pharmacy community, both within Nigeria and across the African continent, pauses not merely to celebrate the anniversary of your birth, but to honour the profound *therapeutic impact* of your existence on our profession.

As the National Chairman of the Clinical Pharmacists Association of Nigeria (CPAN), an entity that stands as your most definitive institutional outcome, it is my distinct privilege and honour to articulate a birthday message that, while heartfelt, is formulated with the clinical specificity your legacy deserves.

Today, we do not just say "Happy Birthday"; we conduct a therapeutic drug monitoring of your life's work. The indications are clear: a lifelong commitment to elevating pharmacy practice . The peak serum concentrations achieved—evidenced by CPAN's global brand —are unprecedented and directly correlated to your expert stewardship. The side effects ? None observed, only immense positive outcomes for our profession. The prognosis for continued impact ? Excellent.

Your career is a masterclass in evidence-based practice. You identified a *critical drug-use* problem—the *underutilization of the clinical pharmacist's expertise within the Nigerian healthcare system. You then designed and implemented a robust intervention: the founding of CPAN. You meticulously *monitored* its growth, adjusted its strategies, and now, we have irrefutable *outcomes* data: a formidable association that pioneers international conferences, sets practice standards, and fiercely advocates for the role of the clinical pharmacist as an *indispensable member of the healthcare team.*

Under your pioneering Chairmanship, you didn't just lead an association; you performed a pharmacogenomic analysis on Nigerian pharmacy. You understood our unique professional genotype and tailored an intervention —CPAN—that perfectly matched our potential, unlocking a phenotype of global excellence and respect we never knew we could express.

Your work has been the essential enzyme inducer, accelerating the metabolism of our professional practice from a traditional, product-focused model to a dynamic, patient-centred clinical paradigm. You have successfully inhibited the enzyme of professional limitation , allowing the active metabolite of clinical excellence to achieve a higher, more effective concentration in the systemic circulation of African healthcare.

Beyond CPAN, your current role as the *Convener of the African Society of Clinical Pharmacists (ASOCLIP)* demonstrates your understanding of the continuum of care. You recognized that *optimal patient outcomes* are not confined by borders, and so you are scaling this model continent-wide, ensuring knowledge transfer and *collaborative practice across Africa* .

Dr. Madu, you are the gold standard , the active control against which leadership in clinical pharmacy is measured. Your brilliance is not merely academic; it is a functional, practical brilliance that has directly improved the quality of care for countless patients through the pharmacists you have inspired and trained.

On behalf of the National Executive Committee and every member of CPAN, we wish you a birthday that is as *efficacious* and *well-tolerated* as your contributions have been. May your day be filled with immense joy, reflection on a journey well-travelled, and the love of family, friends, and colleagues who hold you in the highest esteem.

Thank you for your immeasurable contributions. Thank you for being our pioneer, our mentor, and our global icon.

With the highest level of professional respect and warm regards,

Dr. Maureen Nwafor, PharmD, FPCPharm, MBA, SCPAN,
National Chairman,
Clinical Pharmacists Association of Nigeria (CPAN).

CPAN !!!.. advancing direct patient care through Clinical Pharmacy practice, research and education.

03/09/2025

NEPHROLOGY PHARMACY SPECIALISTS : Who are these healthcare specialists ?

The research and treatment of kidney related disorders is the focus of the discipline of Nephrology, which is an important frontier in modern healthcare.
According to the World Health Organization ( WHO ), an estimated 10% of the world population is affected by Chronic Kidney Disease ( CKD ), and the numbers continue to escalate.
Renal ( kidney) Replacement Therapy ( RRT ) , which includes hemodialysis and peritoneal dialysis is an essential component of End Stage Renal Disease ( ESRD ) care.
Drug dializability, or drug removal due to dialysis is an important consideration in ESRD patient care.
Many drugs require dosage adjustments , supplemental dosing, or alternative timing of administration, while others should be avoided completely due to dialytic clearance.

Another very important consideration is that STANDARD TREATMENT GUIDELINES ( STGs ) may not apply directly to ESRD population, as many clinical trials that influence guideline recommendations often exclude patients with ESRD.
Pharmacists trained in the pharmacology of CKD and ESRD understand the many deviations from standard treatment in the general population.

Driven by the emergence of the Doctor of Pharmacy clinical degree in the 1960s and 70s, pharmacists today graduate with a wide variety of skills. They are trained in Pharmacotherapy , which incorporates knowledge of pharmacokinetics ( drug distribution, metabolism and excretion) , mechanism of drug interactions, pharmacodynamics ( drug concentration and effects relationships) and human pharmacology ( drug chemistry and action ).
Many pharmacy graduates have qualifications or certifications beyond the PharmD degree, including RESIDENCY and / or fellowship training in specialty areas such as NEPHROLOGY.

As expected, renal pharmacists also called NEPHROLOGY pharmacists govern renal drugs expenditure. They also have a high profile role in anaemia management, renal bone disease and hypertension, as well as in outpatient clinics and training of all grades of staff.
Nephrology trained pharmacists have been actively involved in educating other practicing pharmacists in the area of CKD since the early 1990s.
For instance, several Nephrology Pharmaceutical Care training programs hosted by professional organizations such as American Society of Health System Pharmacists ( ASHP ) and academia were developed to train pharmacists caring for patients with CKD..

Today, patients depend on pharmacist's clinical functions that are well beyond their traditional dispensing roles. Primary Care physicians now advocate inclusion of pharmacists in collaborative patient management models.
Patients with CKD , especially stages 3 through 5 , require numerous medications to prevent short and long term complications, and manage comorbidités, including anaemia, metabolic bone disease, hypertension and other cardiovascular diseases. Patients requiring hemodialysis therapy are reported to use an average of 10 to 20 medicines daily, with some patients requiring as many as 20 to 30 medicines doses per day. This so much number of drug taken concurrently can have serious clinical implications.

Despite the significant contributions of Nephrology Pharmacists, this healthcare specialized area has a number of problems. When compared to the increasing frequency of kidney disorders, the shortage of Nephrology Pharmacists is a significant problem.
Professional growth and partnership with academic institutions will be important in solving the problem.

Nephrology Pharmacists work closely with Nephrologists, transplant surgeons, Nurses, and other healthcare professionals to create Pharmaceutical Care methods that are customized to each patients specific requirements.
They also contribute to developing treatment guidelines and conducting research to improve care. They are involved in the medication management for patients undergoing dialysis, those with Acute Kidney Injury ( AKI ) , and post transplant patients.
Some work in community settings in primary care to identify and optimize patients with CKD early. They therefore help to prevent acute kidney injury, delay the progression of CKD , and reduce morbidity and mortality.

In Africa, the full integration of nephrology pharmacists into the renal multidisciplinary team (MDT) can improve quality of life, reduce unnecessary drug use and hospitalizations, and lead to better outcomes for patients with kidney disease.
In South Africa, tertiary hospitals have explored the current roles , potential future roles, and challenges faced by pharmacists in kidney or renal care, recommending strategies to improve participation in the renal multidisciplinary team ( MDT ).
The Nephrology Pharmacists of Nigeria Specialty Group of the Clinical Pharmacists Association of Nigeria (CPAN) is a good example of a professional Nephrology Pharmacy group in Africa.

COURTESY :
African Society of Clinical Pharmacists ( ASOCLIP ).

Join ASOCLIP today to help advance Human Health and Clinical Pharmacy In African Countries & beyond.

To join ASOCLIP as a Pharmacist, kindly contact via WhatsApp ;
+227 90 96 53 39,
+2348033367881,
+256 779 816896,
+233 24 482 5108 , or
+234 803 723 3500.

( WhatsApp Chats only)

26/08/2025

PAEDIATRIC PHARMACY SPECIALIST CLINICAL PHARMACISTS.

WHY THEIR ROLE IS SO IMPORTANT.....

Children are not little adults. Each age , stage of development and condition has its own challenges and considerations that a Paediatric Pharmacist need to be aware of and account for when selecting treatment for the patient.

Children's bodies process drugs differently from those of adults. The liver and kidneys which are vital for drug processing, are immature in children, significantly impacting how they handle medicines.
The physiological differences in weight, body surface area , and development vary significantly within the paediatriç age group , therefore requiring highly specialized care..

Children are at a higher risk of drug therapy problems ( DTPs) compared to adults, leading to increased child & infant morbidity and mortality.
To address these challenges, clinical pharmacists require specialized Postgraduate training in paediatriçs to develop the necessary expert knowledge, and skills for safe and effective medicines use management in children and adolescents.

Pharmacists understand the unique paediatric pharmacokinetic and Pharmacodynamic principles.

Paediatric Pharmacy specialists act as vital members of the healthcare team, offering information to other healthcare professionals, educating parents and caregivers, and working to overcome unique challenges like the lack of age appropriate drug formulations and the diverse physiological needs of young patients.
These specialists have in-depth knowledge of drug use across different Paediatric age groups, from neonates to adolescents, encompassing various disease states and clinical specialties.
They serve as primary sources of evidence based information for healthcare providers and parents regarding new drugs, adverse effects, drug interactions and pharmacokinetics in children.
These pharmacists are skilled in calculating paediatric doses, which differ significantly from adult doses, and addressing issues with appropriate drug formulations, and extemporaneous preparation of medications for children when necessary. They collaborate with physicians and nurses, participating in clinical rounds, medication reconcilliation, and patient education to ensure a comprehensive and integrated approach to paediatriç care.
Their specialized knowledge and interventions are therefore crucial in reducing medication errors in the paediatriç population.

There are several different pathways to becoming a paediatric pharmacy specialist ; however most pathways require additional years of training, experience and residency after obtaining the doctor of pharmacy degree or its equivalent.
Some individuals may seek to obtain the paediatriç pharmacy fellowship.

Paediatriç pharmacy specialists can work in a variety of settings, including hospitals, clinics and community pharmacies. Children's hospitals are a common practice settings for paediatriç pharmacists , as these facilities typically have a higher volume of paediatriç patients, and require specialized medication management for this patient population.
Paediatriç pharmacy specialists may also work in specialty clinics for cystic fibrosis, oncology ( cancer ) , or paediatriç cardiology.
They may also work in research and academic settings where they teach pharmacy and other related clinical fields students.

In Africa , paediatriç pharmacy specialists are an emerging group.
The international society of paediatriç oncology ( SIOP ) Africa technical working group has been active in developing a locally relevant and African sensitive training curriculum for paediatriç oncology pharmacy.
The SIOP Africa 2024 pharmacy workshop resulted in the *approval of a specialized paediatriç oncology pharmacy curriculum*, which is seen as a critical step to address education and training gaps.
However, it is important to emphasize that the practice of paediatriç oncology pharmacy ( POP ) has been in existence for several decades, but most practitioners lack the requisite training and credentialing.
The African Continental branch of the *International Society of Paediatriç Oncology* known as SIOP Africa comprises Pharmacists , Physicians, Nurses, Nutritionists, members of civil societies, and other professionals in Paediatriç Oncology.

COURTESY ( Dr Joseph Madu PharnD) , for :
African Society of Clinical Pharmacists (ASOCLIP).

Join ASOCLIP today to help advance Clinical Pharmacy and Human Health In African Countries & beyond.

To join ASOCLIP, kindly contact via WhatsApp Chats:

+227 90 96 53 39,
+233 24 482 5108,
+234 80333 67881,
+256 779 816896 , or
+234 803 723 3500.
( WhatsApp Chats Only )

21/08/2025

CLINICAL ONCOLOGY PHARMACY SPECIALISTS.

Who are these specialist healthcare professionals ?

A Clinical Oncology Pharmacist is a specialized pharmacist who focuses on the medication management of cancer patients. They are experts in cancer treatments, including chemotherapy, and they play a vital role in ensuring safe, effective and appropriate drug therapy for patients throughout their cancer journey, from diagnosis to survivorship.

They work as part of a multidisciplinary team, including physicians, nurses and other healthcare professionals to optimize patient care.
Oncology Pharmacists also focus on managing symptoms and side effects associated with cancer treatments, ensuring patients have the best possible quality of life.
Clinical Oncology Pharmacists involvement spans all phases of cancer care, from initial diagnosis through treatment and into survivorship. They also play a role in clinical trials and research related to cancer treatments.

They have special training on how to design, give, monitor, and change chemotherapy for cancer patients. They play a crucial role in preventing medication errors, drug interactions and adverse drug reactions, especially with chemotherapy and other high-alert medications.
These specialist pharmacists provide medication and guidance related to supportive care , such as pain management, infection prevention and nausea control.
These Pharmacists also play a role in providing care for patients with advanced cancer and those in survivorship.

They work closely with oncologists and other healthcare professionals to develop and implement treatment plans. Their training and certification typically involves obtaining a Doctor of Pharmacy ( PharmD ) degree or its equivalent and then pursuit of residency training.

In essence, clinical oncology pharmacy specialists are experts in the complexities of cancer treatment, ensuring that cancer patients receive the best possible care through safe, effective and personalized medication management.

Pharmacists are extensively trained clinicians with a wide breadth of knowledge in all areas of healthcare , but are particularly focused on medication utilization.
Despite their terminal degree or professional doctorate ( PharmD), they may also complete postgraduate residency training to further develope clinical and operational skills in specialty areas such as oncology.
They are also skilled at communicating complex medical information to the lay person, and therefore are perfectly positioned to provide educational background to informatics teams, to help them understand the bigger picture, this is particularly helpful in niche oncology areas like bone marrow transplant.

COURTESY :
*African Society of Clinical Pharmacists (ASOCLIP)*

Join ASOCLIP today to help advance Human Health and Clinical Pharmacy In African Countries & beyond.

To join ASOCLIP, kindly chat via WhatsApp.
+227 90 96 53 39,
+233 24 482 5108,
+234 803 723 3500 ,
+256 779 816896 or
+234 803 336 7881.
( *WhatsApp Chats Only* )

Cedith pharmaceuticals & Cedith Clinical Pharmacy

07/09/2025

07/09/2025

04/09/2025

03/09/2025

26/08/2025

21/08/2025

Address

Telephone

Website

Alerts

Contact The Practice

Shortcuts

Share

Category